An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

Por Evelien Moorkens, Arnold G. Vulto, Isabelle Huys
Publicado em 2020-01-01

Biosimilars for Haematologic Malignancies: The Path to Sustainable Care

Por Paul Cornes, Arnold G. Vulto, Wojciech Jurczak
Publicado em 2017-08-01

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Por Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Publicado em 2020-10-01

Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease

Por Qiushi Liang, Eva C. Vlaar, Fabio Catalano, Joon M. Pijnenburg, Merel Stok, Yvette van Helsdingen, Arnold G. Vulto, Wendy W.J. Unger, Ans T. van der Ploeg, W.W.M. Pim Pijnappel, Niek P. van Til
Publicado em 2022-06-01

Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.

Por Erhard van der Vries, Koert J Stittelaar, Geert van Amerongen, Edwin J B Veldhuis Kroeze, Leon de Waal, Pieter L A Fraaij, Roland J Meesters, Theo M Luider, Bart van der Nagel, Birgit Koch, Arnold G Vulto, Martin Schutten, Albert D M E Osterhaus
Publicado em 2013-01-01